首页> 外文期刊>Genetic Testing >Central Retinal Vein Occlusion Secondary to Clomiphene Treatment in a Male Carrier of Factor V Leiden
【24h】

Central Retinal Vein Occlusion Secondary to Clomiphene Treatment in a Male Carrier of Factor V Leiden

机译:氯米芬治疗男性V型莱顿携带者继发的中央视网膜静脉阻塞。

获取原文
获取原文并翻译 | 示例
           

摘要

We report a case of a 35-year-old previously healthy man treated with clomiphene for infertility, who presented with blurred vision in his left eye due to ocular vein occlusion as documented by fluorescein angiography. The patient was heterozygous for the factor V Leiden (FV Leiden) mutation and for the 1298 A-C polymorphism of the methylene-tetrahydrofolate reductase (MTHFR) gene. He was treated with clopidogrel and is now free of symptoms. Because congenital thrombophilia is a moderate risk factor for central retinal vein occlusion and the administration of clomiphene may trigger this process, we recommend screening of young patients for FV Leiden before clomiphene treatment.
机译:我们报告了一例35岁以前健康的人,他因克罗米芬治疗不孕症,由于荧光血管造影术证实眼静脉阻塞导致左眼视物模糊。该患者对于因子V莱顿(FV Leiden)突变和亚甲基四氢叶酸还原酶(MTHFR)基因的1298 A-C多态性是杂合的。他接受了氯吡格雷治疗,现在没有症状。由于先天性血友病是视网膜中央静脉阻塞的中度危险因素,克罗米芬的给药可能会触发此过程,因此我们建议在克罗米芬治疗之前筛查年轻患者的FV Leiden。

著录项

  • 来源
    《Genetic Testing》 |2009年第2期|155-157|共3页
  • 作者单位

    Haematology Laboratory, Attikon University Hospital, Athens, Greece;

    Haematology Laboratory, Attikon University Hospital, Athens, Greece 8 Athan. Diakou St. 14671 Kastri Athens Greece;

    Haematology Laboratory, Attikon University Hospital, Athens, Greece;

    Haematology Laboratory, Attikon University Hospital, Athens, Greece;

    Department of Ophthalmology, Medical School of Athens University, Athens, Greece;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号